{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:33:21Z","timestamp":1777102401553,"version":"3.51.4"},"reference-count":55,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wroclaw University Medical","award":["SUBK.D150.21.097"],"award-info":[{"award-number":["SUBK.D150.21.097"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Proteins with different functions, such as Hepatocyte growth factor activator inhibitor type 1 (HAI-1), Stathmin 1 (STMN-1), and Tenascin C (TN-C), whose activity has been observed in various types of cancers, inspired our study in bladder cancer (BC) patients. The aim of the study was to evaluate selected parameters and their combinations in the diagnosis of BC. The study took into account the degree of invasiveness and malignancy of BC. Based on the analysis of the Receiver Operating Characteristic Curve (ROC), the diagnostic value of single parameters and their combinations as potential indicators of BC was assessed. Patients and Methods: The research material consisted of urine samples from patients with BC, and urine samples from a control group without urological diseases. The concentrations of the examined parameters were measured using an immunoenzymatic method. Results: Statistically significant higher concentrations of HAI-1 (p \u2264 0.001), STMN-1 (\u22640.001) and TN-C (0.002) were found in the patients with BC compared to the control group. Strong relationships were shown between these parameters. ROC analyses showed that the best single parameter for detecting BC is STMN-1, and in the combination of HAI-1+STMN-1. The highest diagnostic value was obtained for the combination of HAI-1+STMN-1 in the patients with high malignancy (sensitivity 82%, specificity 91%). Conclusions: Preliminary studies of parameters have shown their utility as potential markers in BC, especially of STMN-1 and combinations HAI-1+STMN-1. However, to learn more about the contribution of these parameters to the progression of bladder cancer, it would be appropriate to continue the studies.<\/jats:p>","DOI":"10.3390\/jcm14113664","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T06:35:09Z","timestamp":1747982109000},"page":"3664","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Usability Evaluation of Urinary HAI-1, STMN-1 and TN-C in the Diagnosis of Bladder Cancer"],"prefix":"10.3390","volume":"14","author":[{"given":"Beata","family":"Szyma\u0144ska","sequence":"first","affiliation":[{"name":"Department of Toxicology, Faculty of Pharmacy, Wroclaw Medical University, 211 Borowska Street, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5933-3753","authenticated-orcid":false,"given":"Bartosz","family":"Ma\u0142kiewicz","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive and Robotic Urology, Centre of Excellence in Urology, Wroclaw Medical University, 213 Borowska Street, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Dembowski","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive and Robotic Urology, Centre of Excellence in Urology, Wroclaw Medical University, 213 Borowska Street, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Piwowar","sequence":"additional","affiliation":[{"name":"Department of Toxicology, Faculty of Pharmacy, Wroclaw Medical University, 211 Borowska Street, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Cheung, W.W.L., Leung, C., Wong, M.C.S., Fung, F.D.H., Ng, C.F., and Goggins, W.B. (2018). The global epidemiology of bladder cancer: A joinpoint regression analysis of its incidence and mortality trends and projection. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-19199-z"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Saginala, K., Barsouk, A., Aluru, J.S., Rawla, P., Padala, S.A., and Barsouk, A. (2020). Epidemiology of Bladder Cancer. Med. Sci., 8.","DOI":"10.3390\/medsci8010015"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1476-069X-11-S1-S11","article-title":"Bladder cancer, a review of the environmental risk factors","volume":"11","author":"Mosoiu","year":"2012","journal-title":"Environ. Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s43046-020-00055-z","article-title":"Urinary schistosomiasis and the associated bladder cancer: Update","volume":"32","author":"Zaghloul","year":"2020","journal-title":"J. Egypt. Natl. Cancer Inst."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4236\/abb.2013.48A2002","article-title":"Cyclophosphamide Induces an Early Wave of Acrolein-Independent Apoptosis in the Urothelium","volume":"4","author":"Hughes","year":"2013","journal-title":"Adv. Biosci. Biotechnol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.juro.2010.01.014","article-title":"Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer","volume":"183","author":"Yee","year":"2010","journal-title":"J. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Barone, B., Finati, M., Cinelli, F., Fanelli, A., Del Giudice, F., De Berardinis, E., Sciarra, A., Russo, G., Mancini, V., and D\u2019Altilia, N. (2023). Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence. J. Pers. Med., 13.","DOI":"10.3390\/jpm13030512"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.2174\/1389557515666150909141404","article-title":"The Use of Biomarkers for Bladder Cancer Diagnosis and Surveillance","volume":"16","author":"Roupret","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11934-017-0748-x","article-title":"Recent Developments in the Search for Urinary Biomarkers in Bladder Cancer","volume":"18","author":"Leiblich","year":"2017","journal-title":"Curr. Urol. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.urolonc.2007.06.002","article-title":"UroVysion FISH test for detecting urothelial cancers: Meta-analysis of diagnostic accuracy and comparison with urinary cytology testing","volume":"26","author":"Hajdinjak","year":"2008","journal-title":"Urol. Oncol."},{"key":"ref_11","first-page":"221","article-title":"Urinary biomarkers for the diagnosis of urothelial bladder cancer","volume":"3","author":"Ward","year":"2017","journal-title":"New Horiz. Transl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.3390\/cancers6041890","article-title":"Mechanisms of Hepatocyte Growth Factor Activation in Cancer Tissues","volume":"6","author":"Kawaguchi","year":"2014","journal-title":"Cancers"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1349-7006.2010.01808.x","article-title":"Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells","volume":"102","author":"Fukushima","year":"2011","journal-title":"Cancer Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MPA.0000000000000088","article-title":"The RON receptor tyrosine kinase in pancreatic cancer pathogenesis and its potential implications for future targeted therapies","volume":"43","author":"Kang","year":"2014","journal-title":"Pancreas"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/path.3993","article-title":"Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells\u2019 invasiveness","volume":"228","author":"Baba","year":"2012","journal-title":"J. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1517\/14728222.2012.696101","article-title":"Stathmin 1: A protein with many tasks. New biomarker and potential target in cancer","volume":"16","author":"Nemunaitis","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jtcvs.2017.03.125","article-title":"Prognostic impact of stathmin 1 expression in patients with lung adenocarcinoma","volume":"154","author":"Shimizu","year":"2017","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/labinvest.2014.124","article-title":"Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer","volume":"95","author":"Nie","year":"2015","journal-title":"Lab. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.athoracsur.2019.02.040","article-title":"Stathmin-1 Is a Useful Diagnostic Marker for High-Grade Lung Neuroendocrine Tumors","volume":"108","author":"Shimizu","year":"2019","journal-title":"Ann. Thorac. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/19336918.2015.1008332","article-title":"Tenascin-C and integrins in cancer","volume":"9","author":"Yoshida","year":"2015","journal-title":"Cell Adhes. Migr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/19336918.2015.1008331","article-title":"Tenascin C in metastasis: A view from the invasive front","volume":"9","author":"Lowy","year":"2015","journal-title":"Cell Adhes. Migr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12079-009-0075-1","article-title":"The role of tenascin-C in tissue injury and tumorigenesis","volume":"3","author":"Midwood","year":"2009","journal-title":"J. Cell Commun. Signal."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1038\/s41388-020-01506-6","article-title":"Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma","volume":"39","author":"Angel","year":"2020","journal-title":"Oncogene"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"20945","DOI":"10.18632\/oncotarget.7976","article-title":"Tenascin-C serum levels and its prognostic power in non-small cell lung cancer","volume":"7","author":"Gebauer","year":"2016","journal-title":"Oncotarget"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.3892\/mmr.2014.2628","article-title":"Hepatocyte growth factor activator inhibitor type 1 in cancer: Advances and perspectives (Review)","volume":"10","author":"Zheng","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1023051500010","article-title":"Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF\/scatter factor","volume":"22","author":"Kataoka","year":"2003","journal-title":"Cancer Metastasis Rev."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Sakugawa, C., Haruyama, Y., Tanaka, H., Fukushima, T., Kawaguchi, M., and Kataoka, H. (2017). Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma. BMC Res. Notes, 10.","DOI":"10.1186\/s13104-017-3014-x"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/febs.13971","article-title":"The role of type II transmembrane serine protease-mediated signaling in cancer","volume":"284","author":"Tanabe","year":"2017","journal-title":"FEBS J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/bfgp\/elt021","article-title":"Prostate cancer invasion and metastasis: Insights from mining genomic data","volume":"12","author":"Hudson","year":"2013","journal-title":"Brief Funct. Genom."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jsb.2006.07.018","article-title":"Structure and thermodynamics of the tubulin-stathmin interaction","volume":"158","author":"Steinmetz","year":"2007","journal-title":"J. Struct. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0092-8674(00)81037-5","article-title":"Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules","volume":"84","author":"Belmont","year":"1996","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0955-0674(01)00289-7","article-title":"The oncoprotein 18\/stathmin family of microtubule destabilizers","volume":"14","author":"Cassimeris","year":"2002","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1091\/mbc.10.1.105","article-title":"Dissociation of the tubulin-sequestering and microtubule catastrophe-promoting activities of oncoprotein 18\/stathmin","volume":"10","author":"Howell","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1074\/jbc.M510661200","article-title":"Stathmin strongly increases the minus end catastrophe frequency and induces rapid treadmilling of bovine brain microtubules at steady state in vitro","volume":"281","author":"Manna","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1499-3872(14)60038-2","article-title":"Stathmin destabilizing microtubule dynamics promotes malignant potential in, cancer cells by epithelial-mesenchymal transition","volume":"13","author":"Lu","year":"2014","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Chiquet-Ehrismann, R., and Tucker, R.P. (2011). Tenascins and the importance of adhesion modulation. Cold Spring Harb. Perspect. Biol., 3.","DOI":"10.1101\/cshperspect.a004960"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1242\/jcs.190546","article-title":"Tenascin-C at a glance","volume":"129","author":"Midwood","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/ar.22985","article-title":"Tenascin-C in development and disease of blood vessels","volume":"297","author":"Yoshida","year":"2014","journal-title":"Anat. Rec."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1007\/s00018-011-0783-6","article-title":"Advances in tenascin-C biology","volume":"68","author":"Midwood","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0022-5347(05)65157-9","article-title":"Contemporary management of stage T1 transitional cell carcinoma of the bladder","volume":"167","author":"Soloway","year":"2002","journal-title":"J. Urol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/BF03262330","article-title":"The health economics of bladder cancer: A comprehensive review of the published literature","volume":"21","author":"Botteman","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-5347(05)66428-2","article-title":"Current bladder tumor tests: Does their projected utility fulfill clinical necessity?","volume":"165","author":"Lokeshwar","year":"2001","journal-title":"J. Urol."},{"key":"ref_43","first-page":"681","article-title":"The role of the BLCA-4 nuclear matrix protein in bladder cancer","volume":"71","year":"2017","journal-title":"Postep. Hig. I Med. Doswiadczalnej"},{"key":"ref_44","first-page":"1069","article-title":"Evaluation of NMP22 in bladder cancer patients sensitive to environmental toxins","volume":"26","author":"Pawlik","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Szyma\u0144ska, B., Sawicka, E., Guzik, A., Zdrojowy, R., and D\u0142ugosz, A. (2017). The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens. BioMed Res. Int., 2017.","DOI":"10.1155\/2017\/9643139"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ferro, M., Falagario, U.G., Barone, B., Maggi, M., Crocetto, F., Busetto, G.M., Giudice, F., Terracciano, D., Lucarelli, G., and Lasorsa, F. (2023). Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement. Diagnostics, 13.","DOI":"10.3390\/diagnostics13132308"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"25244","DOI":"10.18632\/oncotarget.25397","article-title":"Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification","volume":"9","author":"Snell","year":"2018","journal-title":"Oncotarget"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Yamasaki, K., Mukai, S., Nagai, T., Nakahara, K., Fujii, M., Terada, N., Ohno, A., Sato, Y., Toda, Y., and Kataoka, H. (2018). Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123708"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Mukai, S., Yamasaki, K., Fujii, M., Nagai, T., Terada, N., Kataoka, H., and Kamoto, T. (2020). Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082663"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1479-5876-12-199","article-title":"Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder","volume":"21","author":"McNeil","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/cas.13156","article-title":"Hepatocyte growth factor\/MET in cancer progression and biomarker discovery","volume":"108","author":"Matsumoto","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/bjc.2013.157","article-title":"Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma","volume":"108","author":"Shimwell","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/bjc.2014.427","article-title":"The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer","volume":"111","author":"Hemdan","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.urolonc.2011.02.018","article-title":"Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder","volume":"30","author":"Dubosq","year":"2011","journal-title":"Urol. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/jcp.2004.016576","article-title":"Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer","volume":"57","author":"Brunner","year":"2004","journal-title":"J. Clin. Pathol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/11\/3664\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:39:05Z","timestamp":1760031545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/11\/3664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":55,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["jcm14113664"],"URL":"https:\/\/doi.org\/10.3390\/jcm14113664","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}